untitled



Similar documents
ares_018


6.indd

15690B_表紙1-4.pdf

GDP TFP CRD

2: VPN Australia, Austria, Canada, China, Denmark, Finland, Germany, Hong Kong, India, Indonesia, Italy, Kenya, Korea, Republic of, Malaysia, N

M-JUSD2471b


GDP 10 GDP Bureau of Economic Analysis 2

Descartes Systems Group

# _ qxd

& Groovy TM Shorty TM

ParkOptions&ACC_2001_Jap.ai

EPSON Safety Instructions Manual

国際比較からみた介護システムの役割分担

II a b b c d m a. 2 1

NX10_150223J16AB_0116.ai

main.dvi

F4_LIFULL_A4_16P_pantone2018c

GNH Gross National Happiness Criteria living standard cultural diversity emotional well being health education time use eco-system community vitality

Microsoft PowerPoint - SeminarNaft-I-Re.IntISMS&Standards-V

VAS xlsx

ドメイン名に関する各種統計資料

Dynamics-NAV

2 24

untitled

IP Triple Play Copyright 2006, Allied Telesis Holdings, A rights reserved.

担保資産としての金

MDGs Millennium Development Goals MDGsMDGs C

Company_2801.ai

prd s _1253(2).pdf

花井清人 25‐58/25‐58

Yubidenwa Apple Apple iphone ipod touch ipad itunes Apple Inc. 1

<4D F736F F D C837C815B83678E C982C282A282C4816A2E646F63>

Digestive Endoscopy (DEN) の 国際化と発展 岩手医科大学内科学講座消化器内科消化管分野 松本主之 Digestive Endoscopy (EIC)

Microsoft Word - 10 統計 参考.doc

untitled

食品、飲料、製薬、医療用途向けシーリングソリューション

[ OASIS SAMPLE-EXTRACTION PRODUCTS ] LC-MS HPLC UPLC 1

世界経済の見通しと政策課題

サステナビリティ報告書

環境報告書

437“ƒ

平成 30 年 1 月中対外 対内証券投資 ( 速報 ) Portfolio Investment Assets/Liabilities, January 2018 (Preliminary) ( 付表 3 / Appendix table 3) 対外 対内証券投資 Portfolio Invest

001

平成 29 年 7 月中対外 対内証券投資 ( 速報 ) Portfolio Investment Assets/Liabilities, July 2017 (Preliminary) ( 付表 3 / Appendix table 3) 対外 対内証券投資 Portfolio Investmen

Microsoft Word - AY2017F MFR Application Guideline J

スライド 1

スライド 1


Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo

参考:労働統計機関一覧|データブック国際労働比較2018|JILPT

RISO P ‘C’³

PowerPoint プレゼンテーション

Foreword

-February GDP GDP

(bitcoin) 2013 (1) (2) ( M ) (3) (Satoshi Nakamoto) (4) 20


PowerPoint プレゼンテーション

Dynamics-NAV

調査資料 -253 国際 国内会議録の簡易分析に基づく 我が国の人工知能研究動向把握の試み 2016 年 8 月 文部科学省科学技術 学術政策研究所 科学技術予測センター 小柴等

工業意匠の国際登録制度:ハーグ条約

世田谷区新型インフルエンザ対策行動計画

[ GLYCAN ANALYSIS SLUTINS ] [ GLYCAN ANALYSIS SLUTINS ] N N 3 2


[] 1

Briefs Topics Regional Business May

Transcription:

2005 10 13 Dr. RGA

19602000 10 Australian Institute of of Health and and Welfare 2004 ABS Cat. Cat. No. No. 3201.0; AIHW National Population Database

1875 2 211997 8 122164 http://www.wowzone.com/calment.htm http://www.recordholders.org/en/list/oldest.html

/ 4

10010020 Picture from National Centre for Biotechnology Information Genes and Disease

DNA

. Deaths per Year 106,000 80,000 45,000 12,000 7,000 250,000 Cause

Cancer Statistics in Japan 2003

Cancer Statistics in Japan 2003

- -

1988 1993 1998 2003

mmhg mmhg Chobanian, AV et al. JAMA. May 21, 2003 Vol. 289 No. 19, pg 2560-2571

Table. 95 HERS + WHI + WHI Table from Hulley SB et al, JAMA. 2004;291:1769-1771

70 60 50 40 30 20 10 0 India Ghana China Philippines Japan Morocco Tunisia Togo Mauritius Kyrgyzstan Seychelles Malaysia Hong Kong Norway France Italy Netherlands Switzerland Sweden Brazil Denmark Austria Turkey South Africa Mexico Spain Belgium Canada New Zealand Kuwait Hungary Uruguay Germany United Saudi Arabia Australia Neth Antilles United Finland Jordan Samoa % Men Women U S A Swinburn B et al. WHO (2001) www.heartstats.org

Samoa Kuwait United Kingdom New Zealand Mauritius United States Australia Germany Switzerland Netherlands Brazil Finland South Africa Sweden Canada China Japan France India Italy Malaysia -0.20 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 Average % increase per annum Swinburn B et al. WHO (2001) www.heartstats.org

Source - JAMA. 2003;289:76-79

65 Figure from Olshansky, SJ et al, NEJM, March 17,2005;352 (11):1138

65 1981 1984 1995 1980-2000 Figure from Olshansky, SJ et al, NEJM, March 17,2005;352 (11):1138

X 16-35 100 400,000 100 36-40 100 200,000 750,000 41-45 500,000 200,000 500,000 2 M 2 M 46-50 500,000 200,000 350,000 2 M 2 M 51-55 500,000 200,000 250,000 1 M 1 M 56-60 250,000 200,000 100,000 1 M 1 M 61+ 100,000 200,000 50,000 500,000 500,000 US

??

CHD BMI 10 Source: Rexrode KM, et al, JAMA 1998;280:1843-1848

1 150mg/dl(1-7mmol/L) HDL 40mg/dl(1-03mmol/L) 50mg/dl(1-23mmol/L) 130mmH 85mmHg Lancet, Sept 24 2005;366;1059-62 100mg/dL(5-6mmol/L) 5.6mmol/L 100mg/dL

TABLE 2. N 95 N 95 0 695 10.8 1 645 10.8 1 1 2077 32.2 1.79 1.11, 2.89 * 1932 32.3 2.36 0.71, 7.93 2 1984 30.8 2.25 1.40, 3.60 ** 1819 30.5 4.50 1.39, 14.6 * 3 1339 20.8 3.19 1.98, 5.12 ** 1256 21.0 7.26 2.25, 23.4 ** 4 352 5.4 3.65 2.11, 6.33 ** 322 5.4 24.4 7.53, 79.6 ** *P 0.05 **P 0.01

C-CRP) Figure from Sattar N et al. Circulation July 2003;108:414-419

/2000

Pell 58 Pell JP, BMJ. 2003 January 18; 326 (7381): 134 135

19401979

37

http://www.nlm.nih.gov/medlineplus/ency/imagepages/18056.htm

697 246 (35.3%) 21 (3.0%) : 80% 100% : 91.7% 33.3% Lee HK et al, Yonsei Med J. 2003 Dec 30;44(6):1040-4

Breslow 1.5mmClark 3 TNMT1a T1b 1cmT1N0M0 RAI3 HIV 41

30%-50% have not had a mammogram in past 2 years 27% of women over the age of 65 have never had a PAP smear screen for cervical cancer 70% of at risk public not getting colon cancer screening

47

PSA Figure from Oliver SE el al, Lancet 2000 May 20;355(9217):1788-9

PSA 1/3 NMP48 PSA

St. Jude s Children s Research Hospital Cancer Survival Rates 51

: HIV :

SARS O157 O157 C HIV Figure from Morens, DM et al, Nature. 2004 Jul 8;430(6996):242-9

A (H5N1) A 1961

WHO 28 A(H5N1) : 2003 12 26 2004 3 10 0 0 23 16 12 8 0 0 35 24 2004 7 19 2004 10 8 0 0 4 4 5 4 0 0 9 8 2004 12 16 4 3 64 21 0 0 4 4 71 28 : 4 3 91 41 17 12 4 4 116 60 WHO Communicable Disease Surveillance & Response (CSR), September 29, 2005

H5N1 H5N1 (oseltamavir zanamavir) H5N1

1918, 105,000,000 500,000 0.5 1957, 170,000,000 70,000 0.04% ICU ( 58% )

1918 Source: http://www.cdc.gov/ncidod/eid/vol3no4/lederber.htm

???? 200 700 25% 0.37-2.5%. 400. 15,000 100,000400X0.37 2.5???

64 5,949

http://www.discover.com/july_01/featbros.html